DNLI — DENALI THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 305 家机构在其最新 13F 申报中持有 DNLI(DENALI THERAPEUTICS INC),合计申报市值 $4.74B,对应 170.35M 股。按股数计算较上季度增持 6.7%(+10.04M 股),申报市值环比上升 42.2%。持仓集中度较高:前五大持有人占申报市值的 36.4%,前十大的集中度为 51.8%。
与上一季度相比,54 家新建仓位、123 家加仓、70 家减仓、33 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
DENALI THERAPEUTICS INC(DNLI)的主要机构持有人包括 T. Rowe Price Investment Management, Inc.、BlackRock Inc、Baillie Gifford & Co,按 13F 申报市值在本页 507 家持有人中排名居前。
DNLI 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 218 | 95.60M | $1.98B | -1.0% |
| Q2 2026 | 305 | 170.35M | $4.74B | +5.0% |
| Q1 2026 | 282 | 160.80M | $3.03B | -0.5% |
| Q4 2025 | 256 | 166.30M | $2.68B | +5.9% |
| Q3 2025 | 239 | 155.08M | $2.19B | -3.7% |
| Q2 2025 | 229 | 159.29M | $2.14B | -4.9% |
| Q1 2025 | 222 | 161.44M | $2.14B | +8.0% |
| Q4 2024 | 221 | 149.19M | $2.98B | -1.4% |
表内 8 个季度中,机构持股合计减少 36%(Q4 2024 → Q3 2026);单季变动最大的是 Q1 2025(+8.0%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 14.33M | $296.17M | 0.01% | 增持 | |
| 11.12M | $229.85M | 0.22% | 减持 | |
| 7.01M | $144.96M | 0.41% | 持有 | |
| 6.76M | $139.70M | 0.01% | 增持 | |
| 6.75M | $139.55M | 0.00% | 增持 | |
| 6.68M | $138.12M | 0.00% | 增持 | |
| 4.53M | $93.70M | 0.00% | 持有 | |
| 4.04M | $83.50M | 0.00% | 增持 | |
| 2.92M | $60.33M | 0.01% | 增持 | |
| 2.56M | $52.98M | 0.01% | 持有 | |
| 2.50M | $51.75M | 0.02% | 减持 | |
| 2.46M | $50.86M | 0.02% | 增持 | |
| 1.59M | $32.96M | 0.04% | 减持 | |
| 1.54M | $31.89M | 0.03% | 增持 | |
| 1.52M | $31.43M | 0.04% | 增持 | |
| 1.40M | $28.87M | 0.69% | 持有 | |
| 1.37M | $28.35M | 0.00% | 增持 | |
| 1.27M | $26.27M | 0.01% | 减持 | |
| 1.07M | $22.19M | 0.10% | 减持 | |
| 1.06M | $21.87M | 0.04% | 减持 | |
| 1.06M | $21.87M | 0.01% | 增持 | |
| 854.68K | $17.67M | 0.00% | 增持 | |
| 803.42K | $16.61M | 0.03% | 增持 | |
| 783.16K | $16.19M | 0.00% | 减持 | |
| 625.00K | $12.92M | 1.77% | 持有 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
新建仓(Q2 2026)
- Banque Cantonale Vaudoise 17.93K 股 · $461.00M
- GEODE CAPITAL MANAGEMENT, LLC 3.97M 股 · $102.21M
- Sixth Street Partners Management Company, L.P. 1.24M 股 · $32.02M
- ExodusPoint Capital Management, LP 336.57K 股 · $8.66M
- E. Ohman J:or Asset Management AB 160.00K 股 · $4.12M
- Odyssean, LLC 125.06K 股 · $3.22M
- PFM Health Sciences, LP 100.97K 股 · $2.60M
- Integral Health Asset Management, LLC 100.00K 股 · $2.57M
- Phocas Financial Corp. 71.20K 股 · $1.83M
- Jupiter Topco LLC 60.03K 股 · $1.54M
- Savvy Advisors, Inc. 45.19K 股 · $1.16M
- TUDOR INVESTMENT CORP ET AL 40.97K 股 · $1.05M
完全清仓(较上季)
- STATE STREET CORP 卖出 6.27M 股 · $120.42M
- Vestal Point Capital, LP 卖出 1.77M 股 · $34.05M
- STEMPOINT CAPITAL LP 卖出 426.56K 股 · $8.19M
- BRAIDWELL LP 卖出 296.32K 股 · $5.69M
- SCHRODER INVESTMENT MANAGEMENT GROUP 卖出 285.82K 股 · $5.17M
- Palo Alto Investors LP 卖出 234.58K 股 · $4.50M
- SECTOR GAMMA AS 卖出 162.71K 股 · $3.12M
- Greenland Capital Management LP 卖出 99.00K 股 · $1.90M
- Y-Intercept (Hong Kong) Ltd 卖出 78.01K 股 · $1.50M
- Caption Management, LLC 卖出 74.60K 股 · $1.43M
- Polen Capital Management 卖出 65.30K 股 · $1.25M
- Janus Henderson Group 卖出 60.03K 股 · $1.15M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 14.33M | 14.03M | 13.03M | 12.72M | 12.29M | 12.05M | 13.83M | 13.92M | 13.79M | — | — | — | — | — | — | — | — | — | — | — |
| Baillie Gifford & Co | 11.12M | 11.96M | 12.07M | 12.31M | 11.59M | 11.96M | 12.09M | 12.31M | 13.35M | 13.76M | 14.04M | 14.26M | 14.68M | 14.84M | 15.35M | 15.12M | 14.72M | 14.87M | 14.98M | 15.06M |
| Temasek Holdings (Private) Ltd | 7.01M | 7.01M | 7.01M | 7.01M | 5.36M | 5.36M | 5.36M | 5.36M | 5.36M | 5.71M | 5.71M | 6.90M | 6.90M | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.76M | 6.48M | 6.12M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.75M | 6.28M | 6.15M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 6.68M | — | 6.27M | 6.26M | 5.46M | 4.52M | 4.46M | 4.54M | 4.25M | 4.43M | 6.32M | 5.49M | 4.28M | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 4.53M | 4.54M | 4.58M | 6.10M | 6.34M | 7.54M | 7.41M | 8.02M | 7.83M | 234.87K | 1.23M | 641.65K | 1.06M | 1.08M | 1.09M | 2.21M | 2.45M | 2.87M | 2.94M | 2.95M |
| Geode Capital Management | 4.04M | 3.97M | 3.73M | 3.46M | 3.47M | 3.17M | 3.04M | 2.94M | 2.96M | 2.98M | 2.76M | 2.66M | 2.53M | 2.32M | 2.15M | 2.05M | 1.78M | 1.71M | 1.63M | 1.63M |
| DIMENSIONAL FUND ADVISORS LP | 2.92M | 2.86M | 2.69M | 2.37M | 2.36M | 2.41M | 2.10M | 1.86M | 1.56M | 1.42M | 1.33M | 1.12M | 973.23K | — | — | — | — | — | — | — |
| Capital Research Global Investors | 2.56M | 2.57M | 2.51M | 3.73M | 4.76M | 4.75M | 4.77M | 5.48M | 7.91M | 7.13M | 6.05M | 2.91M | 2.88M | — | — | — | — | — | — | — |
| UBS Group AG | 2.50M | 3.12M | 2.57M | 2.40M | 2.01M | 950.76K | 788.43K | 852.86K | 141.40K | 136.22K | 343.88K | 290.99K | 109.70K | 131.94K | 127.35K | 120.18K | 42.45K | 6.38K | 39.11K | 92.35K |
| Fisher Asset Management, LLC | 2.46M | 2.41M | 2.44M | 2.59M | 1.63M | 1.52M | 1.36M | 792.50K | 547.33K | 478.11K | 469.17K | — | — | — | — | — | — | — | — | — |
| Pictet Asset Management Holding SA | 1.59M | 2.79M | 2.56M | 1.33M | 499.16K | 415.11K | 343.96K | 19.36K | 16.55K | 13.80K | 13.80K | 439.22K | 589.50K | — | — | — | — | — | — | — |
| BNP Paribas Asset Management Holding S.A. | 1.54M | 1.36M | 296.50K | 298.79K | 1.27K | 1.14K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Aberdeen Group plc | 1.52M | 1.35M | 1.85M | 2.03M | 1.11M | 902.75K | 759.82K | 402.28K | 363.68K | 573.03K | 516.02K | 324.83K | — | — | — | — | — | — | — | — |
| Siren, L.L.C. | 1.40M | 1.40M | 1.40M | 1.40M | 821.51K | 821.51K | 821.51K | 834.03K | 834.03K | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 1.37M | 961.05K | 1.10M | 1.22M | 1.69M | 1.31M | 1.25M | 1.23M | 1.74M | 1.22M | 928.13K | 977.49K | 981.57K | 1.08M | 569.12K | 432.49K | 681.33K | 423.01K | 705.65K | 287.26K |
| Principal Global Investors | 1.27M | 1.42M | 1.48M | 1.52M | 1.27M | 1.07M | 1.08M | 1.13M | 1.24M | 1.09M | 1.12M | 1.07M | 680.08K | 686.49K | 488.96K | 526.46K | 545.87K | 267.73K | 269.00K | 330.27K |
| Candriam S.C.A. | 1.07M | 1.19M | 1.10M | 1.17M | 833.58K | 844.25K | 858.16K | 832.98K | 942.16K | 726.50K | 447.88K | 357.88K | 357.88K | — | — | — | — | — | — | — |
| Artisan Partners Limited Partnership | 1.06M | 1.22M | 1.10M | — | — | — | 612.44K | 1.05M | 1.09M | 1.14M | 365.83K | 383.94K | 406.62K | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold DNLI?
As of 2026-Q2, 305 institutional funds reported holding DNLI (DENALI THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $4.74B.
How many shares of DNLI do institutions own?
13F filers reported 170.35M shares of DNLI, worth $4.74B in aggregate at the end of 2026-Q2.
Is institutional ownership of DNLI rising or falling?
Share counts moved +6.7% versus the prior quarter — accumulation.
Who are the top institutional holders of DNLI?
The largest 13F holders are T. Rowe Price Investment Management, Inc., BlackRock Inc, Baillie Gifford & Co, Vanguard Group, Temasek Holdings; the top 25 are ranked at the top of this page.
Who are the major shareholders of DENALI THERAPEUTICS INC?
The major shareholders of DENALI THERAPEUTICS INC (DNLI) by reported 13F value are T. Rowe Price Investment Management, Inc., BlackRock Inc, Baillie Gifford & Co, Vanguard Group, Temasek Holdings, among 507 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.